4.7 Article

Blood Neuroexosomal Mitochondrial Proteins Predict Alzheimer Disease in Diabetes

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

Synaptic basis of Alzheimer's disease: Focus on synaptic amyloid beta, P-tau and mitochondria

Albin John et al.

Summary: Alzheimer's disease is a progressive disease associated with synaptic dysfunction, with researchers striving to find more information on disease progression and pathogenesis. Synaptic pathology and mitochondrial oxidative damage are early events in the progression of AD, with synaptic loss and damage being key correlates of cognitive deficits in patients. As the disease advances, significant changes occur at the synapse, shedding light on the disease progression and serving as potential markers and therapeutic targets.

AGEING RESEARCH REVIEWS (2021)

Review Biochemistry & Molecular Biology

Mitochondrial Dysfunction in Alzheimer's Disease: A Biomarker of the Future?

Simon M. Bell et al.

Summary: Alzheimer's disease is the most common cause of dementia globally, characterized by amyloid beta and tau protein accumulation with currently no approved treatment. In addition to protein aggregation, other pathological changes and early alterations in mitochondrial function are present. Mitochondrial dysfunction caused by amyloid and tau may serve as potential biomarkers for early detection of AD, but further research with larger patient cohorts is needed for clinical application.

BIOMEDICINES (2021)

Article Neurosciences

Altered Amyloid-β and Tau Proteins in Neural-Derived Plasma Exosomes of Type 2 Diabetes Patients with Orthostatic Hypotension

Jinbiao Zhang et al.

Summary: The presence of orthostatic hypotension in diabetes mellitus patients is independently associated with elevated levels of amyloid-beta (A beta), total tau (T-tau), and tau phosphorylated at threonine 181 (P-T181-tau) in neural-derived plasma exosomes, indicating a potential mechanism for the progression of Alzheimer's disease.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Review Cell Biology

Exosomes: Innocent Bystanders or Critical Culprits in Neurodegenerative Diseases

Margarida Beatriz et al.

Summary: Extracellular vesicles (EVs) are nano-sized particles released by cells that facilitate intercellular communication by transferring biological material. Recent studies suggest that exosomes, a type of EV, play a crucial role in the spread of neurodegenerative diseases by carrying genetic material and proteins. This review focuses on the role of exosomes in central nervous system homeostasis, their potential contribution to neurodegenerative diseases, the use of exosome cargo as disease biomarkers, and the benefits of circulating CNS-derived exosomes in plasma.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemical Research Methods

L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma

Maia Norman et al.

Summary: L1CAM, previously thought to be a marker for neuron-derived extracellular vesicles, has been shown to not be associated with extracellular vesicles in human plasma or cerebrospinal fluid, and is therefore not recommended for use in NDEV isolation protocols.

NATURE METHODS (2021)

Article Clinical Neurology

In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease

Tatsuhiro Terada et al.

NEUROLOGY (2020)

Review Neurosciences

Mitochondria and Mitochondrial Cascades in Alzheimer's Disease

Russell H. Swerdlow

JOURNAL OF ALZHEIMERS DISEASE (2018)

Review Endocrinology & Metabolism

Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications

Geert Jan Biessels et al.

NATURE REVIEWS ENDOCRINOLOGY (2018)

Review Neurosciences

The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

Ying Cheng et al.

FRONTIERS IN NEUROSCIENCE (2018)

Review Neurosciences

The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins

Prashant Bharadwaj et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Review Pharmacology & Pharmacy

The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier

Junichi Matsumoto et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Article Biochemistry & Molecular Biology

Critical analysis of Alzheimer's amyloid-beta toxicity to mitochondria

Yury G. Kaminsky et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2015)

Review Clinical Neurology

Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans

Paul S. Aisen et al.

ALZHEIMERS & DEMENTIA (2010)

Article Multidisciplinary Sciences

Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model

Heng Du et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Neurosciences

Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons

Myriam Escobar-Khondiker et al.

JOURNAL OF NEUROSCIENCE (2007)

Article Multidisciplinary Sciences

Mitochondrial Oxidative Stress Causes Hyperphosphorylation of Tau

Simon Melov et al.

PLOS ONE (2007)

Review Clinical Neurology

Risk of dementia in diabetes mellitus: a systematic review

GJ Biessels et al.

LANCET NEUROLOGY (2006)

Article Biochemistry & Molecular Biology

Mitochondrial regulation of synaptic plasticity in the hippocampus

M Levy et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)